Statistical Analysis of FDA's Inspection Findings

Recommendation
27/28 May 2025
Implementation of a Cross Contamination Control Strategy
The deficiencies observed by FDA inspectors are written down in the so-called Form 483. Unlike Warning Letters, those aren't available online and have to be requested individually by post. Yet, FDA's evaluation of findings listed according to their frequency is pretty unknown. This is a very easy way to find out frequently observed deficiencies. In the fields "Drugs" for example, the lack of or the non-compliance with written instructions is ranked first. The second position goes to failures in the investigation of deviations.
The observation summary counts more than 5.000 483 Forms - including in addition to drugs also further fields like foods which have been analysed separately.
Another interesting summary is the webpage with FAQs relating to the 483 Form.
The following graph shows an analysis of the 483 identified during fiscal year 2013.
Related GMP News
14.05.2025Process Validation and Pharmaceutical Water Deficiencies at a US Manufacturer
07.05.2025Another FDA Warning Letter for Indian API manufacturer
30.04.2025Cross-Contamination at Indian pharmaceutical manufacturer
23.04.2025Data Integrity Violations at an OTC Manufacturer
23.04.2025Warning Letter to Indian API Manufacturer due to Restricted Access